Literature DB >> 14984453

The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart.

A Ceriello1, A Cavarape, L Martinelli, R Da Ros, G Marra, L Quagliaro, L Piconi, R Assaloni, E Motz.   

Abstract

OBJECTIVE: Recently, much attention has been focused on the possibility that the post-prandial state may be a cardiovascular risk factor in diabetes. The aim of the present study was to evaluate whether the post-prandial state is associated with endothelial dysfunction in patients with diabetes and to explore the effect on this aspect of managing post-prandial hyperglycaemia by insulin aspart. RESEARCH DESIGN AND METHODS: Twenty-three patients with Type 2 diabetes and 10 normal controls were recruited. In the diabetic patients two different tests were performed in each subject: a standard meal preceded by subcutaneous injection of soluble insulin (0.15 U/kg body weight) or of short-acting insulin aspart (0.15 U/kg body weight). These tests were designed to achieve different levels of post-prandial hyperglycaemia. Controls received a single standard meal test. Immediately before, and 1, 2, 4 and 6 h after each meal, blood glucose, triglycerides, free fatty acids and flow-mediated vasodilation were measured.
RESULTS: Compared with regular insulin, insulin aspart significantly reduced the area under the curve for post-prandial hyperglycaemia (58.3 +/- 17.6 vs. 68.1 +/- 17.7; P<0.04), and preserved flow-mediated vasodilation, which was decreased in the post-prandial state (39.4 +/- 2.9 vs. 34.1 +/- 2.2; P<0.01). Triglyceride and free fatty acid levels were not differentially affected by the treatment. In normal controls the meal did not affect flow-mediated vasodilation.
CONCLUSION: This study shows that the post-prandial state is accompanied by endothelial dysfunction in Type 2 diabetic patients and that insulin aspart improved endothelial function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984453     DOI: 10.1111/j.1464-5491.2004.01101.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  25 in total

1.  To: Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS (2004) The postprandial state does not impair endothelial function in women with Type 2 diabetes irrespective of glycaemic control. Diabetologia 47:1838-1846.

Authors:  A Ceriello; M Hanefeld; L Leiter; L Monnier; D Owens; N Tajima; J Tuomilehto
Journal:  Diabetologia       Date:  2005-06-10       Impact factor: 10.122

2.  Clinical performance of a device that applies local heat to the insulin infusion site: a crossover study.

Authors:  Guido Freckmann; Stefan Pleus; Antje Westhoff; Lars G Krinelke; Andreas Buhr; Nina Jendrike; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  Ultrasound assessment of flow-mediated dilation.

Authors:  Ryan A Harris; Steven K Nishiyama; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

4.  Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus.

Authors:  Antônio Marcos Vargas da Silva; Luciana de Moraes Penno; Marcello Casaccia Bertoluci; Maria Cláudia Irigoyen; Beatriz D'Agord Schaan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Counterpoint: postprandial glucose levels are not a clinically important treatment target.

Authors:  Mayer B Davidson
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

6.  Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy.

Authors:  Samer Ellahham
Journal:  Clin Epidemiol       Date:  2010-12-12       Impact factor: 4.790

7.  Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.

Authors:  Neil H White; H Peter Chase; Silva Arslanian; William V Tamborlane
Journal:  Diabetes Care       Date:  2008-12-23       Impact factor: 19.112

8.  Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney.

Authors:  Meenalakshmi M Mariappan; Kristin DeSilva; Gian Pio Sorice; Giovanna Muscogiuri; Fabio Jimenez; Seema Ahuja; Jefferey L Barnes; Goutam Ghosh Choudhury; Nicolas Musi; Ralph DeFronzo; Balakuntalam S Kasinath
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-09       Impact factor: 4.249

Review 9.  Atherogenicity of postprandial hyperglycemia and lipotoxicity.

Authors:  Antonio Ceriello; Stefano Genovese
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

10.  Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes.

Authors:  Thomas Forst; Andreas Pfützner; Frank Flacke; Alan Krasner; Cloth Hohberg; Eda Tarakci; Philip Pichotta; Senait Forst; Solomon Steiner
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.